Lewis Drug VP honored by SDPhA
PIERRE, S.D. — Lewis Drug’s VP professional services William "Bill" Ladwig has been selected as the recipient of the 2011 Hustead Award by the South Dakota Pharmacists Association, Lewis Drug has announced.
Ladwig, who has worked for Lewis Drug for 33 years, was selected by his peers in honor of the dedication and service he has shown toward the profession of pharmacy. The award was presented to Ladwig at the association’s recent 125th Annual Convention at the Sioux Falls Convention Center in Sioux Falls, S.D.
The Hustead Award recognizes contributions or service during a career for significant accomplishments that impact the profession in a positive manner. The Hustead Award stresses both the individual’s professional career and the impact they have made on the profession, as well as their community service and personal activities.
"Bill has demonstrated the dedication, resourcefulness, service and caring that has made pharmacy one of the most respected professions in our country," SDPhA president Earl Hinricher said.
Ladwig has participated in numerous committees, including the syringe disposal program with Minnehaha County and the Sioux Falls VA Medical Center; Melanoma Monday Detections Screening; and Growing Healthy Initiative to combat childhood obesity, where they changed the school meal program and promoted healthy food awareness and exercise. Ladwig also received the Hammer Award from former vice president Al Gore. His roles also were crucial in the Sioux Falls first mass immunization program and, most recently, "The Big Squeeze," for high blood pressure awareness and detection.
Nasacort AQ generic enters market
ALLEGAN, Mich. — Teva Pharmaceutical Industries has begun shipping a generic drug for allergies, partnering company Perrigo said Wednesday.
Triamcinolone acetonide nasal spray is a generic version of Sanofi’s Nasacort AQ and is used to treat nasal symptoms of seasonal and year-round allergies in patients ages 6 years and older. The Food and Drug Administration approved the generic version of the drug in 2009. The generic was made by Barr Labs, which Teva acquired a few years ago.
Nasacort AQ had sales of $226 million during the 12-month period ended in May, according to Wolters Kluwer.
Tradjenta now available in U.S. pharmacies
INDIANAPOLIS — A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.
Lilly and BI announced the availability of Tradjenta (linagliptin) in chain and independent pharmacies around the country.
The Food and Drug Administration approved the drug at the beginning of May, though Lilly ran into trouble when Amylin Pharmaceuticals, with which it developed and markets the injected Type 2 diabetes drug Byetta (exenatide), sued Lilly in federal court in an attempt to keep it from using the same sales force to sell both drugs. Amylin alleged that using the same sales force would violate their Byetta agreement because the drugs would compete, but a judge threw out Amylin’s claims.
“The rapid availability of Tradjenta for adults with Type 2 diabetes following FDA approval is a testament to Boehringer Ingelheim and Lilly’s joint commitment to improving patient care,” Boehringer Ingelheim Pharmaceuticals VP cardiovascular and metabolic disorders Wa’el Hashad said. “The health of patients is our first priority, and we work diligently to ensure our medications are accessible for patients. With just once dose to remember for all patients, Tradjenta is an important new treatment option that could help the millions of Americans living with Type 2 diabetes.”